Moderna Advances its Mid stage Covid 19 Trial
Moderna Inc (MRNA) provided an update about its Phase II clinical trial of Covid 19 vaccine candidate. The company reported that it has completed the patient enrollment for both the cohort of the trial. Moderna has already completed the Phase III trial protocol based on the FDA feedback. For its randomized, placebo-controlled Phase III trial, the company will be recruiting nearly 30,000 patients across the US.
Earlier this month, Moderna had released early stage data for the vaccine candidate. The results demonstrated that mRNA-1273 produced protective antibodies